How are SYRE bull call spread max profit and max loss calculated?

Max profit equals strike width minus net debit times 100; max loss equals net debit times 100. Breakeven is long-call strike plus net debit. For the SYRE bull call spread priced from the end-of-day chain at a 30-day expiry (ATM IV 76.60%), the computed maximum profit is $202.50 per contract and the computed maximum loss is -$297.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.

What is the breakeven for a SYRE bull call spread?

The breakeven for the SYRE bull call spread priced on this page is roughly $92.98 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current SYRE market-implied 1-standard-deviation expected move is approximately 21.96%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.

How does current SYRE implied volatility affect this bull call spread?

SYRE ATM IV is at 76.60% with IV rank near 11.52%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

SYRE Bull Call Spread Strategy

SYRE (Spyre Therapeutics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

Spyre Therapeutics, Inc. is a biotechnology firm operating at the preclinical stage, dedicated to creating innovative treatments for individuals afflicted with inflammatory bowel disease (IBD). Among its pipeline candidates is SPY001, a human monoclonal immunoglobulin G1 antibody specifically engineered to target and bind with the a4ß7 integrin. This particular therapy is under development for addressing both ulcerative colitis and Crohn's disease, two forms of IBD. Furthermore, Spyre Therapeutics is advancing SPY002, another human monoclonal antibody that aims to interact with tumor necrosis factor-like ligand 1A (TL1A). A synergistic approach is also being explored with SPY120, a compound that merges the anti-a4ß7 action of SPY001 with the anti-TL1A activity of SPY002. All these programs are currently undergoing preclinical evaluation.

SYRE (Spyre Therapeutics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $5.31B, a beta of 3.06 versus the broader market, a 52-week range of 14-102.06, average daily share volume of 1.4M, a public-listing history dating back to 2016, approximately 73 full-time employees. These structural characteristics shape how SYRE stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 3.06 indicates SYRE has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.

What is a bull call spread on SYRE?

A bull call spread buys an at-the-money call and sells an out-of-the-money call at a higher strike for defined risk and defined reward bounded by the strike width.

Current SYRE snapshot

As of June 29, 2026, spot at $90.00, ATM IV 76.60%, IV rank 11.52%, expected move 21.96%. The bull call spread on SYRE below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 18-day expiry.

Why this bull call spread structure on SYRE specifically: SYRE IV at 76.60% is on the cheap side of its 1-year range, which favors premium-buying structures like a SYRE bull call spread, with a market-implied 1-standard-deviation move of approximately 21.96% (roughly $19.76 on the underlying). The 18-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated SYRE expiries trade a higher absolute premium for lower per-day decay. Position sizing on SYRE should anchor to the underlying notional of $90.00 per share and to the trader's directional view on SYRE stock.

SYRE bull call spread setup

The SYRE bull call spread below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With SYRE near $90.00, the first option leg uses a $90.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed SYRE chain at a 18-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 SYRE shares for the stock leg in covered calls and collars).

Action	Type	Strike / Basis	Premium (est)
Buy 1	Call	$90.00	$6.50
Sell 1	Call	$95.00	$3.53

SYRE bull call spread risk and reward

Net Premium / Debit: -$297.50
Max Profit (per contract): $202.50
Max Loss (per contract): -$297.50
Breakeven(s): $92.98
Risk / Reward Ratio: 0.681

Max profit equals strike width minus net debit times 100; max loss equals net debit times 100. Breakeven is long-call strike plus net debit.

SYRE bull call spread payoff curve

Modeled P&L at expiration across a range of underlying prices for the bull call spread on SYRE. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

P&L at expiration across the modeled underlying-price range. Green shading marks profitable regions, red shading marks loss regions. Dotted purple verticals mark breakevens; the solid dark vertical marks current spot.

Underlying Price	% From Spot	P&L at Expiration
$0.01	-100.0%	-$297.50
$19.91	-77.9%	-$297.50
$39.81	-55.8%	-$297.50
$59.71	-33.7%	-$297.50
$79.60	-11.6%	-$297.50
$99.50	+10.6%	+$202.50
$119.40	+32.7%	+$202.50
$139.30	+54.8%	+$202.50
$159.20	+76.9%	+$202.50
$179.10	+99.0%	+$202.50

When traders use bull call spread on SYRE

Bull call spreads on SYRE reduce the cost of a bullish SYRE stock position by selling a higher-strike call; suited to moderate-move theses where price reaches but does not vastly exceed the short strike.

SYRE thesis for this bull call spread

The market-implied 1-standard-deviation range for SYRE extends from approximately $70.24 on the downside to $109.76 on the upside. A SYRE bull call spread caps both the risk and the reward of a bullish position; relative to an outright long call on SYRE, the spread reduces the cost basis but limits the maximum profit to the strike width minus net debit. Current SYRE IV rank near 11.52% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on SYRE at 76.60%. As a Healthcare name, SYRE options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to SYRE-specific events.

SYRE bull call spread positions are structurally moderately bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. SYRE positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move SYRE alongside the broader basket even when SYRE-specific fundamentals are unchanged. Long-premium structures like a bull call spread on SYRE are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current SYRE chain quotes before placing a trade.

Frequently asked questions

What is a bull call spread on SYRE?: A bull call spread on SYRE is the bull call spread strategy applied to SYRE (stock). The strategy is structurally moderately bullish: A bull call spread buys an at-the-money call and sells an out-of-the-money call at a higher strike for defined risk and defined reward bounded by the strike width. With SYRE stock trading near $90.00, the strikes shown on this page are snapped to the nearest listed SYRE chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are SYRE bull call spread max profit and max loss calculated?: Max profit equals strike width minus net debit times 100; max loss equals net debit times 100. Breakeven is long-call strike plus net debit. For the SYRE bull call spread priced from the end-of-day chain at a 30-day expiry (ATM IV 76.60%), the computed maximum profit is $202.50 per contract and the computed maximum loss is -$297.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a SYRE bull call spread?: The breakeven for the SYRE bull call spread priced on this page is roughly $92.98 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current SYRE market-implied 1-standard-deviation expected move is approximately 21.96%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a bull call spread on SYRE?: Bull call spreads on SYRE reduce the cost of a bullish SYRE stock position by selling a higher-strike call; suited to moderate-move theses where price reaches but does not vastly exceed the short strike.
How does current SYRE implied volatility affect this bull call spread?: SYRE ATM IV is at 76.60% with IV rank near 11.52%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.